Related Experiment Video
Updated: Mar 13, 2026

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
Published on: December 31, 2017
Unexpectedly high incidences of chronic non-bacterial as compared to bacterial osteomyelitis in children
A Schnabel1, U Range2, G Hahn3
1Pediatric Rheumatology and Immunology, Children's Hospital Dresden, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany. anja.schnabel@uniklinikum-dresden.de.
Insights
Chronic non-bacterial osteomyelitis (CNO) and bacterial osteomyelitis (BOM) in children are difficult to distinguish clinically. Whole-body MRI is crucial for diagnosing CNO and ruling out BOM, impacting long-term outcomes.
Area of Science:
- Pediatric rheumatology
- Pediatric infectious diseases
- Pediatric orthopedics
Background:
- Osteomyelitis was historically viewed as solely infectious.
- Inflammatory mechanisms are now recognized as a significant cause of pediatric osteomyelitis.
- Distinguishing between chronic non-bacterial osteomyelitis (CNO) and bacterial osteomyelitis (BOM) is clinically challenging.
Purpose of the Study:
- To compare the clinical and laboratory characteristics of pediatric CNO and BOM.
- To evaluate the utility of whole-body MRI in differentiating these conditions.
- To highlight the importance of accurate diagnosis for long-term patient outcomes.
Main Methods:
- Retrospective chart review of osteomyelitis patients (2004-2014) from multiple pediatric departments.
- Comparison of clinical presentation, laboratory findings, and imaging results between CNO and BOM cohorts.
- Analysis of incidence rates and diagnostic challenges.
Main Results:
- Institutional incidences of CNO and BOM were comparable.
- Clinical and laboratory differentiation between CNO and BOM was largely impossible.
- BOM patients more frequently presented with fever, local inflammatory signs, and abscesses.
- CNO patients showed higher rates of peripheral arthritis, inflammatory bowel disease, and hyperostosis.
- Whole-body MRI in CNO revealed multifocal lesions in 80% of cases (CRMO).
Conclusions:
- Clinical differentiation between pediatric CNO and BOM is difficult.
- Whole-body MRI is essential for detecting subclinical CNO lesions and excluding BOM.
- Further prospective studies are needed to establish evidence-based diagnostic and therapeutic guidelines for CNO.
Abstract:
Historically, osteomyelitis was considered an infectious disorder. More recently, inflammatory mechanisms were recognized causing a significant proportion of pediatric osteomyelitis. This study was to compare characteristics of children with chronic non-bacterial (CNO) and bacterial osteomyelitis (BOM). A chart review of osteomyelitis patients from the departments of pediatrics, pediatric surgery, orthopedic surgery, and oral and maxillofacial surgery was conducted in a tertiary referral center, covering the years 2004-2014. Institutional incidences of CNO (n = 49) and BOM (n = 56) were comparable. Differentiation between CNO and BOM based on clinical or laboratory findings was mostly impossible. However, children with BOM more frequently presented with local inflammatory signs (47 vs. 68 %, p = 0.040), fever (12 vs. 38 %, p = 0.003), and abscesses (0 vs. 39 %, p < 0.001). Peripheral arthritis (14 vs. 0 %, p < 0.001), inflammatory bowel disease (10 vs. 2 %, p = ns), and hyperostosis (29 vs. 4 %, p = 0.001) were more common in CNO. Whole-body MRI was performed in 76 % of CNO patients, unveiling multifocal lesions in 80 % (CRMO). Though considered a rare disorder, institutional incidences of CNO were comparable to BOM, and the discrimination between CNO and BOM solely based on clinical aspects was mostly impossible. This is of special interest, since a correct and timely diagnosis is of utmost importance for long-term outcomes in both disorders. Whole-body MRIs should be considered in chronic osteomyelitis to (1) detect clinically inapparent lesions in CNO and (2) indirectly exclude (usually unifocal) chronic bacterial infections. Prospective studies are warranted to establish evidence-based diagnostic and therapeutic approaches to CNO.

